Detalles de la búsqueda
1.
The "liver-first approach" for patients with locally advanced rectal cancer and synchronous liver metastases.
Dis Colon Rectum
; 52(1): 23-30, 2009 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-19273952
2.
Phase I and pharmacokinetic study of the dolastatin 10 analogue TZT-1027, given on days 1 and 8 of a 3-week cycle in patients with advanced solid tumors.
Clin Cancer Res
; 11(10): 3806-13, 2005 May 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-15897580
3.
Phase I and pharmacologic study of PKI166, an epidermal growth factor receptor tyrosine kinase inhibitor, in patients with advanced solid malignancies.
Clin Cancer Res
; 11(19 Pt 1): 6908-15, 2005 Oct 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-16203782
4.
Phase I and pharmacologic study of oral ZD9331, a novel nonpolyglutamated thymidylate synthase inhibitor, in adult patients with solid tumors.
J Clin Oncol
; 20(7): 1923-31, 2002 Apr 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-11919253
5.
Phase I and pharmacokinetic study of the polyamine synthesis inhibitor SAM486A in combination with 5-fluorouracil/leucovorin in metastatic colorectal cancer.
Clin Cancer Res
; 10(6): 1949-55, 2004 Mar 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-15041711
6.
Phase I and pharmacokinetic study of brostallicin (PNU-166196), a new DNA minor-groove binder, administered intravenously every 3 weeks to adult patients with metastatic cancer.
Clin Cancer Res
; 9(8): 2957-64, 2003 Aug 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-12912942
Resultados
1 -
6
de 6
1
Próxima >
>>